Rhythm Pharmaceuticals (RYTM) PT Raised to $94 at Stifel
Tweet Send to a Friend
(Updated - May 29, 2025 8:36 AM EDT)
Stifel analyst Paul Matteis raised the price target on Rhythm Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Paul Matteis raised the price target on Rhythm Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
